India, May 9 -- AstraZeneca Pharma India has partnered with Vaayu Chest & Sleep Center to elevate the standard of respiratory care for severe asthma patients in Bengaluru.

Severe asthma poses a significant challenge as a prevalent non-communicable disease in India, contributing to premature morbidity and mortality. Recent data indicates that approximately 22 lakhs of individuals in Karnataka are grappling with asthma, placing the state seventh in terms of asthmatic population in India.

The Centers of Excellence (COEs) for severe asthma, aligned with the Global Initiative for Asthma (GINA) guidelines, are designed to offer a systematic and uniform approach to managing patients with severe asthma.

Since the start of this year, AstraZenec...